News

Tethis expands global access to SmartBioSurface® through new channel partners in Brazil, India, China and…

Tethis announces application note of SmartBioSurface® slides for cell suspension workflows on leading spatial biology…

Tethis to launch SmartBioSurface® slides at EACR Conference    Milan, Italy — 8 June 2026,…

Lumito and Tethis complete proof-of-concept study demonstrating compatibility between Lumito’s UCNP imaging and Tethis’ SmartBioSurface®…

The Department of Clinical and Molecular Medicine of Sapienza University of Rome, Takis and Tethis…

Tethis S.p.A. collaborates with Sheba Medical Center to advance AI-powered liquid biopsy in rectal cancer…

Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods…

Tethis S.p.A. collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage…

Tethis S.p.A. announces enrollment of the first two patients in a clinical study of its…

Tethis appoints Holger Neecke as the company's Chief Executive Officer MILAN, Oct. 20, 2022 /PRNewswire/ -- Tethis…